Nanome Webinar Series | AI for the Science Metaverse: how to accelerate drug discovery by using AI in VR featuring scientists from Iktos

In this webinar Alessandro Monge, SVP, Head of US Operations & Business Development at Iktos, and Iktos Application Scientists Brian Atwood and Rohit Arora shared insights on the applications of AI in drug discovery and the impact of VR. 

Iktos has developed two major technologies for use by chemists. Makya, a de novo design platform, enables users to generate new compound ideas with the support of AI. Spaya, a computer-aided synthesis planning tool, provides predicted retrosynthesis routes with a high degree of customization available so that users can find the retrosynthesis that meets their needs.

Iktos scientists discuss how these technologies can be accessed in VR and allow real-time collaboration on compound design and retrosynthesis planning.

https://iktos.ai/
https://www.linkedin.com/in/alessandro-monge/
https://www.linkedin.com/in/brian-atwood-26ab9b27/
https://www.linkedin.com/in/rohiarora/